A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
|Videos|May 24, 2022
Materna Medical discusses new vaginal dilator
Author(s)Lois Levine, MA, Morgan Ebert
Tracy MacNeal, president and CEO of Materna Medical, sits down to discuss the company's recently FDA-cleared Milli Vaginal Dilator for vaginismus and associated dyspareunia, as well as a potential new use for the device currently being studied.
Advertisement
Advertisement
Related to this article
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
FDA approves pritelivir tablets to treat lesions from HSV
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5